ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

China medical investor Alwin Capital closes fund at $300m

Firm specializes in life science investments such as medical robots, equipment

Founded in 2015, Alwin Capital invests in life science companies and has secured the final close of a dual-currency fund.

HONG KONG -- Chinese venture capital firm Alwin Capital said it has secured the final close of a dual-currency fund at $300 million to invest in life and interdisciplinary sciences.

The yuan investors in the dual-currency fund include large funds of funds, Chinese government guidance funds, medical industry and insurance companies, banks and other financial institutions in China, the company said in a statement without divulging names.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more